Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Edinburgh Bioquarter - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9423
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Edinburgh Bioquarter (BioQuarter) is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerative medicine, inflammation and oncology. BioQuarter offers advance drug development by transforming basic scientific discoveries through clinical application into new medical treatments and products. The center collaborates with clinicians, industrialists, patients, scientists, pre-clinical and clinical research facilities. It operates specialist facilities such as an imaging centre, labs for stem-cell work, and clinical trials unit. BioQuarter is headquartered in Edinburgh, the UK.

Edinburgh Bioquarter – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Edinburgh Bioquarter, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Edinburgh Bioquarter, Medical Devices Deals, 2012 to YTD 2018 9
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Eli Lilly Enters Into Co-Development Agreement With University of Edinburgh 11
Edinburgh BioQuarter Enters Into Co-Development Agreement With Galecto Biotech 12
Edinburgh Cancer Research UK Centre And Edinburgh BioQuarter Enter Into Co-Development Agreement With Galapagos 13
Edinburgh Bioquarter – Key Competitors 14
Edinburgh Bioquarter – Key Employees 15
Edinburgh Bioquarter – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Key Facts 2
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Edinburgh Bioquarter, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Edinburgh Bioquarter, Deals By Therapy Area, 2012 to YTD 2018 8
Edinburgh Bioquarter, Medical Devices Deals, 2012 to YTD 2018 9
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eli Lilly Enters Into Co-Development Agreement With University of Edinburgh 11
Edinburgh BioQuarter Enters Into Co-Development Agreement With Galecto Biotech 12
Edinburgh Cancer Research UK Centre And Edinburgh BioQuarter Enter Into Co-Development Agreement With Galapagos 13
Edinburgh Bioquarter, Key Competitors 14
Edinburgh Bioquarter, Key Employees 15

List of Figures
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Edinburgh Bioquarter, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Edinburgh Bioquarter, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependa …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • ADT LLC:戦略・SWOT・企業財務分析
    ADT LLC - Strategy, SWOT and Corporate Finance Report Summary ADT LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Cutera Inc (CUTR):企業の財務・戦略的SWOT分析
    Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Navigo Proteins GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Navigo Proteins GmbH (Navigo Proteins), formerly Scil Proteins GmbH, a subsidiary of UV-Cap GmbH & Co KG, is a protein engineering company that offers generation and optimization of proteins for therapeutic and non-therapeutics. The company provides microbial production of recombinant protei …
  • Sirona Biochem Corp (SBM):企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agent …
  • Banco Santander (Brasil) SA:企業のM&A・事業提携・投資動向
    Banco Santander (Brasil) SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Santander (Brasil) SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Henry Schein, Inc.:企業のM&A・事業提携・投資動向
    Henry Schein, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Henry Schein, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Liberty Oilfield Services Inc (LBRT):企業の財務・戦略的SWOT分析
    Liberty Oilfield Services Inc (LBRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Twist Bioscience Corp (TWST):医療機器:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Selecta Biosciences Inc:企業のM&A・事業提携・投資動向
    Selecta Biosciences Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Selecta Biosciences Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Thomas Cook (India) Limited
    Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sheridan Healthcare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sheridan Healthcare Inc (Sheridan Healthcare), a subsidiary of AmSurg Corp, is a healthcare service provider that offers physician services. The center offers office-based services in the areas of OBGYN, gynecology, gynecologic oncology, perinatology and pain management. It provides support, …
  • ReWalk Robotics Ltd (RWLK):企業の製品パイプライン分析
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company offers walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabilita …
  • Eskom Holdings SOC Limited:企業の戦略・SWOT・財務情報
    Eskom Holdings SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Eskom Holdings SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Curetis NV (CURE)-医療機器分野:企業M&A・提携分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, im …
  • Singapore Power Limited:戦略・SWOT・企業財務分析
    Singapore Power Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NuStar Energy LP (NS):石油・ガス:M&Aディール及び事業提携情報
    Summary NuStar Energy LP (NuStar Energy) is a midstream oil and gas company. It carries out the transportation, terminalling, storage and marketing of petroleum products, and anhydrous ammonia. The company owns and operates pipelines, terminal and storage facilities that store and distribute crude o …
  • Landec Corp (LNDC):企業の財務・戦略的SWOT分析
    Summary Landec Corp (Landec) is a diversified health solution service provider. The company offers offers food and biomaterial solutions. It develops and markets innovative and proprietary based products for healthy living. The company offers various technologies such as application development and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆